Fixing AAV Recovery With Siren Biotechnology’s Nathalie Clément, Ph.D.
In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Nathalie Clément, Ph.D., Siren Biotechnology’s SVP of vector development. The two discuss the historical challenges of purifying AAV vectors and the developments that have allowed for greater product yields. Clément shares where she believes the greatest gains can still be made to improve vector recovery and offers advice for teams seeking to optimize downstream unit operations. Keep up with everything biomanufacturing...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Better Biopharma
Focusing On Quality Unit Independence With Tatyana Matveeva, Ph.D.
Developing Multi-Targeted T-Cell Engagers With Deck Bio’s Johanna Kaufmann
Digitalizing The Biopharma Ecosystem With Kat Kozyrytska
Modulating Multispecific Manufacturability With AP Biosciences’ JJ You, Ph.D.
Get summaries like this every morning.
Free AI-powered recaps of Better Biopharma and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.